StonvexLoading…
StonvexCore line items from TTAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-04 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $261.67M | $960.97M | $706.98M | $457.81M | $215.69M |
Operating Income | Not available | $-169.21M | $-126.53M | $-84.31M | $-49.54M |
Net Income | Not available | $-159.85M | $-118.12M | $-78.59M | $-46.36M |
EPS (Diluted) | $0.27 | $-1.73 | $-1.29 | $-0.86 | $-0.51 |
Total Assets | Not available | $1.75B | $1.82B | $1.78B | $1.73B |
Total Liabilities | Not available | $219.82M | $311.65M | $294.47M | $273.47M |
Cash & Equivalents | Not available | $428.77M | $493.24M | $471.49M | $420.26M |
Free Cash Flow OCF − CapEx | Not available | $105.43M | $65.55M | $23.37M | $-15.86M |
Shares Outstanding | Not available | 92.38M | 91.79M | 91.04M | 90.33M |